Inspections, Compliance, Enforcement, and Criminal Investigations
American Bottling Company - Close Out Letter 4/17/13
Department of Health and Human Services
|Food and Drug Administration|
4040 North Central Expressway
Dallas, Texas 75204-3128
April 17, 2013
RETURN RECEIPT REQUESTED
Phil Forte, Group Plant Manager
American Bottling Company, dba Dr. Pepper Snapple Group
2304 Century Center Blvd.
Irving, TX 75062
Dear Mr. Forte:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions since receiving Warning Letter 2012-DAL-WL-028 issued on July 10, 2012. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Shari J. Shambaugh
Director, Compliance Branch
Dallas District Office